Moderna vaccine appears to work against variants
bbc.co.uk
bbc.co.uk
For example the E484K variant identified in Brazil that is supposed to be antibody resistant is quite terrifying.
That said based on the title you might assume the vaccine to be as effective, but that's not quite what the study says. In short it states:
>A six-fold reduction in neutralizing titers was observed with the B.1.351 variant relative to prior variants. Despite this reduction, neutralizing titer levels with B.1.351 remain above levels that are expected to be protective.
As the vaccine becomes more widespread, it will be tested more widely by exposure to the virus and this will trigger faster evolutionary cycles by the virus to defeat the vaccine.
My forecast is we will have to get much faster at releasing updated vaccines and distributing them in order to stay ahead of this virus -- and that everyone will need to be vaccinated every 6 months until we hit sufficient heard immunity of the circulating strains such that is stops circulating so rapidly and the speed of mutation consequently reduces.
Fortunately, it seems there is openness from the FDA to have a faster approval cycle for vaccine tweaks. Moderna is already working on a "booster shot" to try and increase immunity to the South-African variant.
I wish that we also had other therapeutic tools to combat COVID. I wonder if we couldn't save people who are getting hospitalized by employing drugs that block the receptor the virus uses to enter cells. Similarly to the way HIV is kept under control. That could save lives and it would be more mutation-proof.
If anyone actually cared about this there is an EXISTING mechanism to get business to produce pretty much any quantity of anything you want. You pay them money. Instead the government is constantly canceling contracts, seizing products, stopping the sale of products for more than 10% more than historic prices etc.
ALL these steps REDUCE confidence in making a big / high risk investment.
My guess - if we looked at even existing use of the DPA - probably most stuff got made by folks not expert in making it and sat in a warehouse. I'm serious - I want to know how many ventilators made under DPA by rando companies are actually in use?
I've worked in govt contracting - the govt does not get "the best" producers to produce, in situations like this the hands reach out from the experts playing the govt contracting game. Not end of world normally, but with lives on the line some more standard approaches would be refreshing.
It's possible that the current generation of vaccines could end up being outdated, and there could be some amount of waste, but the important thing is the production rate. When an updated vaccine becomes available, we want to be able to produce it and distribute it as fast as possible.
On another note, there's also research into oral vaccines. IMO that would be amazing if it could pan out. Imagine if we could just mail people capsules containing booster doses updated for the latest strain every month. We'd crush any pandemic in no time.
I guess if you really nail the science, you can make it infectious and vaccinate by breathing on people.
I suppose that a government-funded infectious vaccine would be one way to get anti-maskers to reverse their stance on wearing cloth face coverings...
This is war. Governments fight wars. It's one of the primary roles of government. In WW2 all sorts of prioritization and direction came from government. This should be the same.
https://www.evms.edu/covid-19/covid_care_for_clinicians/#d.e...
"Moderna says it’s working on Covid booster shot for variant in South Africa, says current vaccine provides some protection"
"The company’s researchers said its current coronavirus vaccine appears to work against the two highly transmissible strains found in the U.K. and South Africa, although it looks like it may be less effective against the latter."
https://www.cnbc.com/2021/01/25/covid-vaccine-moderna-workin...
The common cold is a coronavirus. It is significantly less deadly than the seasonal flu. We have every reason to believe that a more contagious but less deadly version will resemble the common cold.
.3% of New York City has already died.
Unless the vast majority of New Yorkers have already contracted the virus, the mortality rate has to be substantially higher than .3%.
SARS-CoV-2 is also only ~3x as deadly as the flu WITH UNPRECEDENTED MEASURES TO CONTAIN IT. In areas where it wasn't contain, such as the initial outbreak in Italy that overwhelmed hospitals, it was 10x or more as deadly as the flu.
So we have no reason to believe this will occur with covid19.
Not necessarily. Assume that people try to self-quarantine as soon as they notice symptoms. (They don't need to be 100% effective at this.) Consider "mutations that affect how quickly it spreads within your body". Those that increase said efficiency would presumably increase the likelihood of death; but they would also probably shorten the "asymptomatic spreading" period, which means they'd get selected against; this selection happens even among those that aren't dying.
(Author background disclaimer: No biology beyond 9th grade.)
LONG TERM, less deadly viruses will tend to spread better because the more deadly a virus is, the more it raises stakes for the host population to remove it or prevent it , and the more it can make it apparent who has been infected. Ebola for instance justifies pretty almost any action you can imagine to contain it's spread, where we are still arguing if lockdowns or travel restrictions are the cost appropriate measure with COVID.
If the time of fatality is sufficiently delayed, or the time to implement other countermeasures or recognize the situation has changed is too long, it doesn't help anyone in the short, medium, or potentially even long term - you can have massive fatalities and huge spread.
The 1918 pandemic had multiple waves, with the second in particular having a much higher fatality rate than the first - 10x a typical flu season, which is what we're seeing now. This was almost certainly caused by variants, though lack of data makes it impossible to prove. [https://en.wikipedia.org/wiki/Spanish_flu]
A particularly nasty example [https://www.adn.com/alaska-news/science/2020/03/22/how-an-al...]
The more infections, the more likely we'll get more variants, and the more likely we'll get some that cause terrible, terrible problems - and may still be quite infectious.
Long term, will the most terrible ones die out? Very likely. However, smallpox was a scourage on humanity since likely 300 BCE and up until eradication by a massive global effort in 1975, it still had fatality rates around 25-35%. So don't just assume COVID will 'evolve to harmlessness', or if it does that it would happen on a timeframe convenient for society [https://www.cdc.gov/smallpox/history/history.html]
Soldiers with minor symptoms remained where they were, not coming in contact with many other people.
The very sickest soldiers were transported by train, where the infected many other people, to hospitals, where they continued infecting many other people. It was our own attempts to care for the soldiers that caused the deadliest strains to spread and continue evolving.
What some folks are proposing in this thread (uncontrolled community spread so it will 'mellow out') is an even more massive expansion of that due to the quite visible ability for COVID to be infectious in patients with no symptoms for long periods of time, which Influenza has not been able to pull off.
Pre-symptomatic infectiousness has about the same selection pressure as low mortality rate IMO. Low risk viruses circulate well because people don’t care about transmission very much. High risk infections cause people to take precaution and thus eliminates those stains. SARS-COV-1 and MERS were that way.
But pre-symptomatic infectiousness (SARS-COV-2) makes this calculus immaterial for most people; they transmit it without knowledge. This reduces the pressure on high mortality / morbidity strains / variants.
My theory is that what they are adapting to is all the other mitigation measures that we've been doing for a while--think masks and social distancing.
Bacteria would have more options, since they're so much more complex. Viruses just don't have much they can do.
Of course they can. We have this pandemic because a coronavirus became highly transmissible.
These mutations are the virus finishing its adaptation to humans. It will eventually end up at a local maxima, just like, say, measles did.
There are many ways for this to happen, some of which covered in this thread - changes in the surface presented to the host, more viral load produced and expelled by an infected host earlier being some obvious ones.
Some potential methods that have occurred with other diseases in the past include additional methods of infecting hosts (from prior versions), such as viral envelopes that can insert against additional types of cells, or changes to the way the virus hijacks cell replication machinery to produce products that are better at hiding what is going on to the immune system.
The virus can't "evolve" its way around not reaching the host very well. Evolution isn't magic. The virus can't "evolve" teleportation or an immunity to high-energy electromagnetic radiation just because it would be really useful to it if it could. It can't just "evolve" its way around masks very well.
As I said, bacteria have at least more options, though they face the same physical constraints everything else in the universe does. Viruses don't really have many options. They are very simple.
Since these vaccines are targeting spike proteins, shouldn't they work with every variant? Is there (big) risk of a mutation actually changing the spike protein?
Key quote: "B.1.1.7 is defined by 23 mutations from the original Wuhan strain, 8 of which are in the spike protein. The 3 mutations hypothesized to have the largest potential biological effect are N501Y, spike deletion 69-70del and P681H."
The B.1.351 (South Africa) variant has N501Y but not the 69-70 deletion. We're still learning, but virologists I follow are concerned that N501Y may be a driver of higher transmission. But it's likely that multiple mutations contribute.
[1]: https://asm.org/Articles/2021/January/B-1-1-7-What-We-Know-A...
If the spike protein mutates, it means that the structure of the spike is different. Obviously the spike can't change too much, because it needs to still be able to latch onto cells, and many changes would be irrelevant. Even if one antibody suddenly stops working because of a slight shift in the protein, there are other antibodies targeting different parts of the protein that would still be effective.
Only if the spike changes so dramatically that literally none of the antibodies you had before are relevant anymore. That's why it's not super expected that we'll get a version of the virus that these vaccines won't at least produce some antibodies against.
"Won't work" in this case is defined on a spectrum. Moderna's vaccine is currently about 90% efficacious. Newer variants could reduce that down to say 60% or more. At some point the current vaccine could become useless.
On the other hand, if you are in a situation where no holds bared screaming to get attention is the norm then it may be good to share information quickly and transparently.
The day later they ran headlines sayign that covid wasn't spreading like wildfire.
The source of the first scaremongering inaccurate dangerous headline was a study which said:
During the period 6 January to 15 January, SARS-CoV-2 virus was circulating with a higher prevalence than between 25 November to 3 December with 158 in 10,000 infected. There was no strong evidence for either growth or decay in prevalence averaged across the period 6 January to 15 January.
Which led to headlines like"Covid-19 cases have increased more quickly since lockdown started in England, study finds"
(Lockdown started on Jan 5th - when about 60,000 cases were being identified each day. The headline was Jan 21st, when about 30,000 cases were identified)
https://inews.co.uk/news/covid-19-cases-england-increase-sin...
The 7 day cases identified from Jan 6th to 15th dropped from 55,885/day to 40,242/day
That either means the number of unidentified cases balooned, or the REACT study was too small to identify changes over the course of a week (it's not designed to). In the former case we'd expect fewer tests were being done, but tests throughout January have remained averaging about 550,000 a day.
The media will print whatever they can, so it's important to give headlines which make it clear the data is inconclusive. "appears" is a weasel-word that is well used in this case, and far better than misreporting a scientific paper
Regardless, the current vaccination campaign is highly effective against the original - still very widespread and deadly - virus, so it's worth getting it, and as people get vaccinated with it, it will eventually be apparent whether it works against various variants as well. If it doesn't, it's likely that a booster vaccination can be developed for these variants (and indeed, Moderna has begun work, as an insurance policy, on a booster for the south african variant).
False hope
The hypothesis is that the Moderna vaccine produces antibodies against the new variant.
8/8 people sampled produced antibodies.
Can we confidently say that 100% of people will produce antibodies? No, not with a sample size of 8.
Can we say confidently that 50% of people will produce antibodies? That the vaccine gives you a coin toss's odds? If it's just a coin toss, this result would be the same probability as 8 "heads" in a row, or 1 in 256.
So, the result is hardly FUD or meaningless. They've also submitted to journals for the world to inspect the results.
Regardless of what this early result is, the only thing most of us can do is try to keep social distancing, use masks, and get vaccinated to protect ourselves as best as possible.
If the vaccine doesn't actually protect us against the newer strains, we should still take it because we need protection from the more widely strain regardless. The only difference is whether we'll need to take a second vaccine in another year.
I believe most of the vaccines approved or pending approval (Johnson and Johnson) target the spike protein, so I would expect their results to likely (hopefully) be similar.
No significant impact on neutralization against the B.1.1.7 variant was detected in either case, however reduced neutralization was measured against the mutations present in B.1.351.
Paper : https://www.biorxiv.org/content/10.1101/2021.01.25.427948v1
When was the last last time we had a disease that spread this quickly and caused this many hospitalisations, on a global scale?
It's already well on its way, from what I can gather.
One frustrating aspect of the reporting for me is people talking about "more infectious" variants without describing whether or not they are more or less dangerous. In general, the virus putting more work into being infectious is good news; it generally comes at the cost of being less dangerous in other ways as it hyper-optimizes into replication rather than anything else. We should expect and want to hear about "more infectious" variants, which double as natural vaccines to some extent against other less infectious, more dangerous strains still using the same external protiens.
People have a hard time with this intuitively, because we probably live under the weakest selection pressure in the history of planet Earth, but it's vicious down there. Viruses are to a large extent playing a zero-sum game. If they get better at one thing, it almost has to come at the cost of something else, because they've already got all the knobs cranked up as high as they will go just to survive and they don't have a spare energy budget just lying around to put into other things without taking away from something else.
It's not impossible that some mutation was made that made it more infectious and more deadly... but it's a long enough shot that I'd consider the likelihood of incomplete early information and incentives that some parties have to amp up the danger in the presence of such uncertainty higher. Viruses do not routinely become more infectious and more deadly. If they did, we'd all be long dead. The evolution gradient tilts strongly away from that.
It's more likely to go the other way; some derpy mutation that reduces viral load, slows incubation, reduces symptoms, makes more super-spreaders.
Say the current mortality rate is 2% and each infected person passes on the disease to one other after a week, then stops being infectious. If 100 people have the virus in week 0, after 10 weeks 1000 people will have had the virus and 20 will have died.
Increase the death rate by 70% and you’d have 34 deaths instead. Increase the transmission rate by 70%, and you’d have 170 people newly infected in week 1, then 289 in week 2, totalling 285,000 infected people, of which 2% die. That’s now 570 deaths.
Obviously the numbers can all be changed somewhat depending on treatment, or whether you expect everyone to be infected at some point anyway, but the takeaway is that more deadly is not necessarily worse than more infectious.
Smallpox would like a word.
Polio, too, for the most part.
The last case of SARS-CoV-1 was in 2004 and the virus is considered eradicated.
https://en.wikipedia.org/wiki/Severe_acute_respiratory_syndr...
A year ago there wasn't much more than experimental capacity to make mRNA vaccines. Now we are at tens of millions of doses a month and scaling up.